New data from three Phase 3 trials show upadacitinib maintains strong efficacy and safety in adolescent atopic dermatitis, with significant improvements in pruritus and skin clearance.
Squamous cell carcinoma is the leading cause of mortality in severe epidermolysis bullosa," notes Dr. Robert Kirsner, as FDA grants rare pediatric designation to mitochondrial-targeting therapy.
A recent study suggests that proactive monitoring of infliximab during maintenance therapy may increase sustained disease control in patients with inflammatory bowel disease and arthritis, potentially adding 146 more patients per 1,000 to annual remission rates.
Research has shown that patients of color prefer seeing doctors of their own race — and some studies have shown health outcomes are better for Black patients seeing Black doctors.
Explore new techniques in corneal transplantation, including Descemet’s membrane endothelial keratoplasty and artificial corneas, for treating corneal diseases.
A new study exposes the alarming levels of medical and educational debt burdening U.S. health care workers, with debt disproportionately affecting women, Black workers, and those in lower-paying fields.